Related references
Note: Only part of the references are listed.1E10 anti-idiotype vaccine in non-small cell lung cancer -: Experience in stage IIIb/IV patients
Saily Alfonso et al.
CANCER BIOLOGY & THERAPY (2007)
Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer -: Report of a phase I trial
Elia Neninger et al.
CANCER BIOLOGY & THERAPY (2007)
Activation state egfr and STAT-3 as prognostic markers in resected non-small cell lung cancer
Tania Cortas et al.
LUNG CANCER (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling
Yihui Liu et al.
CANCER RESEARCH (2006)
Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis
Karim Bennaceur et al.
INTERNATIONAL IMMUNOLOGY (2006)
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc
Juan P. Oliva et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer
EB Haura et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: Role of maturation status and intratumoral localization
MH Sandel et al.
CLINICAL CANCER RESEARCH (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer
AD Santin et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer
TC Mineo et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells
LX Song et al.
ONCOGENE (2003)
Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis
J Péguet-Navarro et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine
A Carr et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas
M Iwamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Role of tumor-associated gangliosides in cancer progression
S Birklé et al.
BIOCHIMIE (2003)
Gangliosides inhibit the development from monocytes to dendritic cells
M Wölfl et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors
A Carr et al.
HYBRIDOMA (2000)
Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer
T Yano et al.
EUROPEAN JOURNAL OF CANCER (2000)